Soy isoflavones on markers of bone turnover in females in the early menopause

INTERVENTION: A bar containing 7.5g isolated soy protein powder (Solcon F) with 33mg of isoflavones (given twice daily) or 7.5g of the isolated soy (extracted, isoflavone free) protein alone (given twice daily) as control will be administered. CONDITION: Effect of soy phyto‐eastrogens to people during menopause as soy have been shown to improve menopausal flusing symptoms. ; Nutritional, Metabolic, Endocrine ; Menopausal and female climacteric states PRIMARY OUTCOME: Change in bone turnover markers SECONDARY OUTCOME: 1. Insulin resistance; 2. Blood pressure; 3. Lipid profile; 4. Endothelial function; 5. Changes in endometrial thickness INCLUSION CRITERIA: 1. Women with a follicle‐stimulating hormone (FSH) and luteinizing hormone (LH) greater than 20 mU/L and amenorrhoea for 1 year with or without vasomotor instability of hot flushing will be eligible to participate 2. Caucasian women